ArticleGastroenterology research and practice2026
A Prognostic Nutritional Scoring System Integrating Inflammatory Markers and Body Composition in Gastric Cancer Patients Undergoing Curative Resection With Prophylactic HIPEC.
Article in Gastroenterology research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Prognostic Nutritional Scoring System Integrating Inflammatory Markers and Body Composition in Gastric Cancer Patients Undergoing Curative Resection With Prophylactic HIPEC.Gastroenterology research and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Nutrition- and inflammation-related indicators have been shown the prognostic value in cancer patients; however, few studies focus on gastric cancer (GC) patients who underwent prophylactic intraperitoneal hyperthermic chemotherapy (p-HIPEC) following radical gastrectomy. This study is aimed at developing and validating a prognostic nutritional scoring system (PNSS) integrating systemic inflammatory markers and body composition parameters specifically for these patients. Methods and Results: Body composition was assessed via computed tomography, and systemic inflammatory markers were recorded preoperatively. A total of 267 patients with GC who received p-HIPEC were included, and the incidences of sarcopenia, myosteatosis, and sarcopenic obesity were 32.6%, 27.3%, and 18.7%, respectively. Logistic regression analysis identified that platelet-to-lymphocyte ratio (PLR) is a significant risk factor for sarcopenia and myosteatosis. The PNSS was constructed using PLR, systemic immune-inflammation index (SII), lymphocyte-to-monocyte ratio (LMR), skeletal muscle index (SMI), and sarcopenia-myosteatosis risk (SMR) score which further integrates skeletal muscle attenuation (MA). This model demonstrated superior predictive accuracy for overall survival (OS) compared to the classic TNM model ( Conclusions: The PNSS, incorporating both body composition and systemic inflammatory markers, provides robust prognostic value for predicting OS in GC patients undergoing curative resection with p-HIPEC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.